Healthcare conglomerate CVS Well being Company (NYSE: CVS) on Wednesday introduced third-quarter 2024 outcomes, reporting a lower in adjusted earnings and a rise in revenues. The highest line exceeded estimates.
September-quarter adjusted revenue decreased 51% year-over-year to $1.09 per share and missed analysts’ estimates. On a reported foundation, internet earnings was $87 million or $0.07 per share in Q3, in comparison with $2.26 billion or $1.75 per share within the prior-year quarter.
In the meantime, revenues elevated 6% year-over-year to $95.4 billion in the course of the three months and topped expectations. Complete same-store gross sales climbed 15.5% year-over-year.
“My dedication to our CVS Well being colleagues and our clients is to drive centered execution of our built-in technique to enhance the well being of the 185 million folks we’re privileged to serve.,” stated CVS CEO David Joyner.
